Related Experiment Video
Updated: May 1, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial
Benjamin A Steinberg1, Sunghee Kim2, Laine Thomas2
1From the Duke University Medical Center, Durham, NC (B.A.S., J.P.P., E.D.P.); Duke Clinical Research Institute, Durham, NC (B.A.S., S.K., L.T., J.P.P., E.D.P.); UCLA School of Medicine, Los Angeles, CA (G.C.F.); Boston University School of Medicine, Boston, MA (E.H.); New York University School of Medicine, Lenox Hill Hospital, New York, NY (J.A.); Kaiser Permanente, Oakland, CA (A.S.G.); Janssen Pharmaceuticals, Inc., Raritan, NJ (P.C.); Lankenau Institute for Medical Research, Wynnewood, PA (P.K.); Mayo Clinic, Rochester, MN (B.J.G.); Stanford University School of Medicine, Palo Alto, CA (K.W.M.); and Harvard Medical School and Massachusetts General Hospital, Boston, MA (D.E.S.). benjamin.steinberg@duke.edu.
Physicians and empirical models show poor agreement on stroke and bleeding risk in atrial fibrillation (AF) patients. This discrepancy may contribute to current anticoagulation treatment decisions diverging from guidelines.
Area of Science:
- Cardiology
- Clinical Medicine
- Health Services Research
Background:
- Atrial fibrillation (AF) management requires balancing stroke prevention with bleeding risk.
- Empirical risk prediction models exist, but their alignment with physician assessments is not well-understood.
Purpose of the Study:
- To compare physician risk assessments with empirical scores for stroke and bleeding in AF patients.
- To investigate factors influencing physician risk assessment compared to established models.
Main Methods:
- Analysis of 10,094 AF patients from the ORBIT-AF registry.
- Comparison of CHADS2 (stroke) and ATRIA (bleeding) scores with physician-assigned risk categories (low, intermediate, high).
Main Results:
- Low agreement observed between empirical scores and physician assessments for both stroke (weighted Kappa 0.1) and bleeding risk (weighted Kappa 0.11).
- Physicians underestimated high stroke risk (16% vs. 72% by CHADS2) and bleeding risk (7% vs. 17% by ATRIA).
- Anticoagulation use correlated with high stroke risk but was minimally impacted by bleeding risk assessments.
Conclusions:
- Significant discordance exists between provider-assessed and empirical risk scores in AF.
- This disagreement may partly explain why anticoagulation choices deviate from clinical guidelines.
More Related Videos
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Measurement of Blood Pressure
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Acute Coronary Syndrome III: Diagnostic Studies

